Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
American Journal of Kidney Diseases
Journal
Overview
Identity
Overview
Publication Venue For
Dialysis Nonadherence and Kidney Transplant Outcomes: A Retrospective Cohort Study
. 80:46-54.
2022
Associations of Plasma Biomarkers of Inflammation, Fibrosis, and Kidney Tubular Injury With Progression of Diabetic Kidney Disease: A Cohort Study
. 79:849-857.e1.
2022
Kidney Disease, Hypertension Treatment, and Cerebral Perfusion and Structure
. 79:677-687.e1.
2022
Kidney Recovery and Death in Critically Ill Patients With COVID-19–Associated Acute Kidney Injury Treated With Dialysis: The STOP-COVID Cohort Study
. 79:404-416.e1.
2022
The Impact of COVID-19 on Nephrology Fellows—A Perspective From the 2020-2021 AJKD Editorial Intern Class
. 78:769-771.
2021
Assessing the Relationship Between Serum Urate and Urolithiasis Using Mendelian Randomization: An Analysis of the UK Biobank
. 78:210-218.
2021
Estimated GFR Variability and Risk of Cardiovascular Events and Mortality in SPRINT (Systolic Blood Pressure Intervention Trial)
. 78:48-56.
2021
Risk Factors for Major Hemorrhage Among Patients Receiving Dabigatran Across the Spectrum of CKD Not Requiring Dialysis Therapy
. 78:151-153.
2021
KDOQI US Commentary on the 2020 KDIGO Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney Transplantation
. 77:833-856.
2021
Burden and Cost of Caring for US Veterans With CKD: Initial Findings From the VA Renal Information System (VA-REINS)
. 77:397-405.
2021
Characteristics and Outcomes of Individuals With Pre-existing Kidney Disease and COVID-19 Admitted to Intensive Care Units in the United States
. 77:190-203.e1.
2021
KDOQI US Commentary on the 2020 ISPD Practice Recommendations for Prescribing High-Quality Goal-Directed Peritoneal Dialysis
. 77:157-171.
2021
State-of-the-Art Management of Hyperphosphatemia in Patients With CKD: An NKF-KDOQI Controversies Perspective
. 77:132-141.
2021
Telehealth for Home Dialysis in COVID-19 and Beyond: A Perspective From the American Society of Nephrology COVID-19 Home Dialysis Subcommittee
. 77:142-148.
2021
The New Age of Vascular Access: Choosing the Right Access for the Right Reason in Older Hemodialysis Patients
. 76:457-459.
2020
KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update
. 75:S1-S164.
2020
Donor-Recipient Relationship and Risk of ESKD in Live Kidney Donors of Varied Racial Groups
. 75:333-341.
2020
APOL1 Nephropathy Risk Alleles and Mortality in African American Adults: A Cohort Study
. 75:54-60.
2020
A Quality Improvement Initiative Targeting CRRT Delivered Dose: The What, the How, and the Why
. 74:721-723.
2019
Second-Chance Placement of Hemodialysis Patients After Involuntary Discharge for Disruptive Behavior
. 74:544-548.
2019
Mortality and Kidney Transplantation Outcomes Among Hepatitis C Virus–Seropositive Maintenance Dialysis Patients: A Retrospective Cohort Study
. 73:815-826.
2019
Quantification of Complications of Tunneled Hemodialysis Catheters
. 73:462-464.
2019
Exploring Barriers and Potential Solutions in Home Dialysis: An NKF-KDOQI Conference Outcomes Report
. 73:363-371.
2019
CureGN Study Rationale, Design, and Methods: Establishing a Large Prospective Observational Study of Glomerular Disease
. 73:218-229.
2019
Relationship of Estimated GFR and Albuminuria to Concurrent Laboratory Abnormalities: An Individual Participant Data Meta-analysis in a Global Consortium
. 73:206-217.
2019
Albuminuria and Allograft Failure, Cardiovascular Disease Events, and All-Cause Death in Stable Kidney Transplant Recipients: A Cohort Analysis of the FAVORIT Trial
. 73:51-61.
2019
The Role of Vitamin D in CKD Stages 3 to 4: Report of a Scientific Workshop Sponsored by the National Kidney Foundation
. 72:834-845.
2018
Tradeoffs in Vascular Access Selection in Elderly Patients Initiating Hemodialysis With a Catheter
. 72:509-518.
2018
Serum Calcitriol Concentrations and Kidney Function Decline, Heart Failure, and Mortality in Elderly Community-Living Adults: The Health, Aging, and Body Composition Study
. 72:419-428.
2018
Changes in Blood Pressure During Young Adulthood and Subsequent Kidney Function Decline: Findings From the Coronary Artery Risk Development in Young Adulthood (CARDIA) Study
. 72:243-250.
2018
Urinary Biomarkers of Kidney Tubular Damage and Risk of Cardiovascular Disease and Mortality in Elders
. 72:205-213.
2018
In Reply to ‘Core Assessment of Predonation Kidney Function: Clarification of the 2017 KDIGO Living Donor Guideline’
. 72:155.
2018
Medicare Costs Associated With Arteriovenous Fistulas Among US Hemodialysis Patients
. 72:10-18.
2018
Hyperuricemia, Acute and Chronic Kidney Disease, Hypertension, and Cardiovascular Disease: Report of a Scientific Workshop Organized by the National Kidney Foundation
. 71:851-865.
2018
Evaluation of Kidney Donors: Core Curriculum 2018
. 71:737-747.
2018
Relationships Between Clinical Processes and Arteriovenous Fistula Cannulation and Maturation: A Multicenter Prospective Cohort Study
. 71:677-689.
2018
Report of the Standardized Outcomes in Nephrology–Hemodialysis (SONG-HD) Consensus Workshop on Establishing a Core Outcome Measure for Hemodialysis Vascular Access
. 71:690-700.
2018
Lessons From International Differences in Vascular Access Practices and Outcomes
. 71:452-454.
2018
Effects of Intensive Blood Pressure Treatment on Acute Kidney Injury Events in the Systolic Blood Pressure Intervention Trial (SPRINT)
. 71:352-361.
2018
Vascular Access Outcomes Reported in Maintenance Hemodialysis Trials: A Systematic Review
. 71:382-391.
2018
Association Between Gestational Diabetes and Incident Maternal CKD: The Coronary Artery Risk Development in Young Adults (CARDIA) Study
. 71:112-122.
2018
KDOQI US Commentary on the 2017 KDIGO Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD)
. 70:737-751.
2017
Cognitive Function and Kidney Disease: Baseline Data From the Systolic Blood Pressure Intervention Trial (SPRINT)
. 70:357-367.
2017
Serum Phosphorus and Risk of Cardiovascular Disease, All-Cause Mortality, or Graft Failure in Kidney Transplant Recipients: An Ancillary Study of the FAVORIT Trial Cohort
. 70:377-385.
2017
Measures of Kidney Disease and the Risk of Venous Thromboembolism in the REGARDS (Reasons for Geographic and Racial Differences in Stroke) Study
. 70:182-190.
2017
Genetics of Blood Pressure: New Insights Into a Complex Trait
. 69:723-725.
2017
Heme Oxygenase 1 as a Therapeutic Target in Acute Kidney Injury
. 69:531-545.
2017
Performance of the CKD-EPI Equation to Estimate GFR in a Longitudinal Study of Autosomal Dominant Polycystic Kidney Disease
. 69:482-484.
2017
Quiz: Acute Kidney Injury and Pancytopenia 5 Months After Kidney Transplantation
. 69:A14-A17.
2017
Central Venous Occlusion in the Hemodialysis Patient
. 68:803-807.
2016
Waist Circumference, Body Mass Index, and ESRD in the REGARDS (Reasons for Geographic and Racial Differences in Stroke) Study
. 67:62-69.
2016
A meta-analysis of the association of estimated GFR, albuminuria, diabetes mellitus, and hypertension with acute kidney injury
. 66:602-612.
2015
Preoperative arterial microcalcification and clinical outcomes of arteriovenous fistulas for hemodialysis
. 66:84-90.
2015
Influence of Kidney Function on Risk of Supratherapeutic International Normalized Ratio-Related Hemorrhage in Warfarin Users: A Prospective Cohort Study
. 65:701-709.
2015
Association of high-sensitivity cardiac troponin t and natriuretic peptide with incident ESRD: The atherosclerosis risk in communities (ARIC) study
. 65:550-558.
2015
KDOQI US commentary on the 2013 KDIGO clinical practice guideline for lipid management in CKD
. 65:354-366.
2015
Validation study of medicare claims to identify older US adults with CKD using the reasons for geographic and racial differences in stroke (REGARDS) study
. 65:249-258.
2015
Community mobility among older adults with reduced kidney function: A study of life-space
. 63:429-436.
2014
Body mass index and early kidney function decline in young adults: A longitudinal analysis of the CARDIA (coronary artery risk development in young adults) study
. 63:590-597.
2014
Chlorthalidone versus hydrochlorothiazide in hypertension treatment: Do we have the evidence to decide?
. 63:387-389.
2014
Dietary patterns and risk of death and progression to ESRD in individuals with CKD: A cohort study
. 64:204-213.
2014
Estimated GFR and risk of hip fracture in older men: Comparison of associations using cystatin C and creatinine
. 63:31-39.
2014
Incident ESRD and treatment-resistant hypertension: The reasons for geographic and racial differences in stroke (REGARDS) study
. 63:781-788.
2014
Is there a role for detection of complement-binding antibodies in kidney transplantation?
. 63:558-560.
2014
Lipid-lowering guidelines and statin use in CKD: A time for change
. 63:736-738.
2014
Objectives and design of the hemodialysis fistula maturation study
. 63:104-112.
2014
Correlation of pre-existing vascular pathology with arteriovenous graft outcomes in hemodialysis patients
. 62:1122-1129.
2013
Renovascular hypertension associated with pseudoaneurysm following blunt trauma
. 62:839-843.
2013
Predialysis vascular access surgery in patients with failing kidney transplants
. 62:398-400.
2013
Trajectories of kidney function decline in young black and white adults with preserved GFR: Results from the coronary artery risk development in young adults (CARDIA) study
. 62:261-266.
2013
Dasatinib-induced nephrotic-range proteinuria
. 61:1026-1031.
2013
α-Klotho and kidney function decline: An important step forward in understanding the link between mineral metabolism and kidney disease progression
. 61:855-857.
2013
Relationships between serum and urine phosphorus with all-cause and cardiovascular mortality: The osteoporotic fractures in men (MrOS) study
. 61:555-563.
2013
Geographic variation in CKD prevalence and ESRD incidence in the united states: Results from the reasons for geographic and racial differences in stroke (REGARDS) study
. 61:395-403.
2013
Influence of kidney function on risk of hemorrhage among patients taking warfarin: A cohort study
. 61:354-357.
2013
Pathologic femur fracture due to a brown tumor in a patient with secondary hyperparathyroidism and vitamin D-resistant rickets
. 61:337-341.
2013
A man with acute kidney injury and cutaneous purpura
. 62.
2013
Fibroblast growth factor 23, high-sensitivity cardiac troponin, and left ventricular hypertrophy in CKD
. 61:67-73.
2013
KDOQI US commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury
. 61:649-672.
2013
KDOQI US commentary on the 2012 KDIGO clinical practice guideline for management of blood pressure in CKD
. 62:201-213.
2013
Screening strategies for tuberculosis in children with kidney disease: What is cost-effective?
. 61:3-5.
2013
Association of hemodialysis central venous catheter use with ipsilateral arteriovenous vascular access survival
. 60:983-989.
2012
Low income and albuminuria among REGARDS (Reasons for geographic and racial differences in stroke) study participants
. 60:779-786.
2012
Predicting successful arteriovenous fistula creation
. 60:498.
2012
Kidney disease education one year after the medicare improvement of patients and providers act: A survey of US nephrology practices
. 59:892-894.
2012
Regional citrate anticoagulation for continuous renal replacement therapy: The better alternative?
. 59:745-747.
2012
Association of factor V gene polymorphism with arteriovenous graft failure
. 59:682-688.
2012
Comparison of concurrent complications of CKD by 2 risk categorization systems
. 59:372-381.
2012
Genetic association and gene-gene interaction analyses in African American dialysis patients with nondiabetic nephropathy
. 59:210-221.
2012
Association of family history of ESRD, prevalent albuminuria, and reduced GFR with incident esrd
. 59:25-31.
2012
Imatinib therapy for non-infection-related type II cryoglobulinemia with membranoproliferative glomerulonephritis
. 59:122-125.
2012
Peripherally inserted central catheters and other intravascular devices: How safe are they for hemodialysis patients?
. 60:510-513.
2012
Albuminuria, kidney function, and the incidence of cognitive impairment among adults in the United States
. 58:756-763.
2011
Medial fibrosis, vascular calcification, intimal hyperplasia, and arteriovenous fistula maturation
. 58:437-443.
2011
Arteriovenous graft placement in predialysis patients: A potential catheter-sparing strategy
. 58:243-247.
2011
Association of waist circumference and body mass index with all-cause mortality in CKD: The REGARDS (Reasons for Geographic and Racial Differences in Stroke) study
. 58:177-185.
2011
Development and validation of a self-assessment tool for albuminuria: Results from the reasons for geographic and racial differences in stroke (REGARDS) study
. 58:196-205.
2011
Fistula first: Recent progress and ongoing challenges
. 57:3-6.
2011
Improving incident fistula rates: A process of care issue
. 57:814-817.
2011
Economic analysis of cinacalcet in combination with low-dose vitamin D versus flexible-dose vitamin D in treating secondary hyperparathyroidism in hemodialysis patients
. 56:1108-1116.
2010
Cystatin C, albuminuria, and 5-year all-cause mortality in HIV-infected persons
. 56:872-882.
2010
Kidney function, albuminuria, and all-cause mortality in the REGARDS (Reasons for Geographic and Racial Differences in Stroke) study
. 56:861-871.
2010
Warfarin dosing in patients with impaired kidney function
. 56:823-831.
2010
A physiologic-based approach to the treatment of acute hyperkalemia
. 56:578-584.
2010
Low medication adherence and hypertension control among adults with CKD: Data from the REGARDS (Reasons for Geographic and Racial Differences in Stroke) Study
. 56:447-457.
2010
Practical Vancomycin Dosing in Hemodialysis Patients in the Era of Emerging Vancomycin Resistance: A Single-Center Experience
. 55:1163-1165.
2010
Hypertension Awareness, Treatment, and Control in Adults With CKD: Results From the Chronic Renal Insufficiency Cohort (CRIC) Study
. 55:441-451.
2010
Cryoglobulinemic Glomerulopathy Complicating Helicobacter pylori-Associated Gastric Mucosa-Associated Lymphoid Tissue Lymphoma
. 54:770-774.
2009
Treatment Guidelines for Dialysis Catheter-Related Bacteremia: An Update
. 54:13-17.
2009
Treatment of Dialysis Catheter-Related Enterococcus Bacteremia With an Antibiotic Lock: A Quality Improvement Report
. 53:107-111.
2009
Management of Hyperuricemia and Gout in CKD
. 52:994-1009.
2008
Kidney Function and Cognitive Impairment in US Adults: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study
. 52:227-234.
2008
Racial Differences in the Competing Risks of Mortality and ESRD After Acute Myocardial Infarction
. 52:251-261.
2008
In Reply
. 52:198.
2008
Metabolic Syndrome, Proteinuria, and the Risk of Progressive CKD in Hypertensive African Americans
. 51:732-740.
2008
Prophylaxis Against Dialysis Catheter-Related Bacteremia: A Glimmer of Hope
. 51:165-168.
2008
Vascular Access: Core Curriculum 2008
. 51:702-708.
2008
In Reply
. 50:1052.
2007
Treatment of Dialysis Catheter-Related Staphylococcus aureus Bacteremia With an Antibiotic Lock: A Quality Improvement Report
. 50:289-295.
2007
Improving Outcomes From Acute Kidney Injury: Report of an Initiative
. 50:1-4.
2007
Arteriovenous Grafts Still Have a Place in Dialysis
. 49:873-874.
2007
Cardiovascular Outcomes in the African American Study of Kidney Disease and Hypertension (AASK) Trial
. 48:739-751.
2006
In Reply
. 48:181-182.
2006
Citrate-Based Replacement Solutions with Continuous Venovenous Hemofiltration: Not as Simple as It Sounds
. 47:1086.
2006
Needle Infiltration of Arteriovenous Fistulae in Hemodialysis: Risk Factors and Consequences
. 47:1020-1026.
2006
Effect of change in vascular access on patient mortality in hemodialysis patients
. 47:469-477.
2006
Current and evolving immunosuppressive regimens in kidney transplantation
. 47.
2006
Sonographic assessment of the severity and progression of autosomal dominant polycystic kidney disease: The Consortium of Renal Imaging Studies in Polycystic Kidney Disease (CRISP)
. 46:1058-1064.
2005
Delay in time to receipt of thrombolytic medication among medicare patients with kidney disease
. 46:595-602.
2005
K/DOQI clinical practice guidelines for bone metabolism and disease in children with chronic kidney disease: Work group membership
. 46.
2005
Tunneled catheters in hemodialysis patients: Reasons and subsequent outcomes
. 46:501-508.
2005
Renal replacement therapies for acute renal failure: Does dose matter?
. 45:1139-1143.
2005
Hepatitis C infection is acquired pre-ESRD
. 45:684-689.
2005
Shorter unassisted patency of vascular access after angioplasty in women [1] (multiple letters)
. 46:167.
2005
Dialysis catheter-related bacteremia: Treatment and prophylaxis
. 44:779-791.
2004
Vascular access stenosis: Comparison of arteriovenous grafts and fistulas
. 44:859-865.
2004
Associations with predialysis vascular access management
. 43:1008-1013.
2004
Hypertension.
. 44:369-375.
2004
Medullary cystic kidney disease type 2 [1] (multiple letters)
. 43:1142-1143.
2004
Transplantation in the diabetic patient with advanced chronic kidney disease: A task force report
. 44:529-542.
2004
Interventional nephrology: Work in progress
. 42:388-391.
2003
Chronic use of sodium ferric gluconate complex in hemodialysis patients: Safety of higher-dose (≥250 mg) administration
. 41:651-657.
2003
Cystic and Inherited Kidney Diseases
. 42:1305-1317.
2003
K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification
. 39.
2002
Maintenance immunosuppression in the renal transplant recipient: an overview.
. 38:S25-S35.
2001
Clinical consequences of infected arteriovenous grafts in hemodialysis patients
. 38:975-978.
2001
Evolution of immunosuppression and continued importance of acute rejection in renal transplantation
. 38.
2001
Maintenance immunosuppression in the renal transplant recipient: An overview
. 38.
2001
Mitochondrial DNA mutations in black Americans with hypertension-associated end-stage renal disease
. 38:529-536.
2001
Predictors of arteriovenous graft patency after radiologic intervention in hemodialysis patients
. 37:945-953.
2001
IgA1 glycosylation and the pathogenesis of IgA nephropathy
. 35:551-554.
2000
Is there a role for Chlamydia pneumoniae in hemodialysis vascular access thrombosis?
. 36:1122-1125.
2000
Natural history of arteriovenous grafts in hemodialysis patients
. 36:68-74.
2000
Mycophenolate mofetil in cadaveric renal transplantation
. 34:296-303.
1999
T594M mutation in the ENaC β subunit and low-renin hypertension in blacks
. 34:579-583.
1999
Homocysteine, b vitamins, and vascular-access thrombosis in patients treated with hemodialysis
. 32:475-481.
1998
Oxygen free radicals and contrast nephropathy
. 32:64-71.
1998
Prospective evaluation of an anemia treatment algorithm in hemodialysis patients
. 32:635-641.
1998
Acute renal failure in the 21st century: Recommendations for management and outcomes assessment
. 29:793-799.
1997
The impact of renal transplantation on survival in hepatitis C- positive end-stage renal disease patients
. 29:608-614.
1997
Benefits of continued cyclosporine through an indigent drug program
. 28:572-577.
1996
Dilemmas in renal transplantation: When the clinical course and histological findings differ
. 27:435-440.
1996
Effect of bicarbonate administration on plasma potassium in dialysis patients: Interactions with insulin and albuterol
. 28:508-514.
1996
Kidney disease in the first-degree relatives of African-Americans with hypertensive end-stage renal disease
. 27:341-346.
1996
Postdialysis fatigue
. 28:732-736.
1996
Salt-sensitive hypertension: Lessons from animal models
. 28:775-782.
1996
Effect of albuterol treatment on subsequent dialytic potassium removal
. 26:607-613.
1995
Liddle's syndrome: A public health menace?
. 25:924-927.
1995
Rapid renal deterioration secondary to oxalate in a patient with diabetic gastroenteropathy
. 26:68-71.
1995
Development of Bacterial Biofilms on Silastic Catheter Materials in Peritoneal Dialysis Fluid
. 23:709-716.
1994
Posttransplant Erythrocytosis: An Enigma Revisited
. 24:1-11.
1994
Immunoglobulin A-Fibronectin Aggregate Levels in Children and Adults With Immunoglobulin A Nephropathy
. 22:1-4.
1993
Reply
. 21:344.
1993
Tapering or Discontinuing Cyclosporine for Financial Reasons—A Single-Center Experience
. 21:9-15.
1993
Extrarenal potassium tolerance in chronic renal failure: implications for the treatment of acute hyperkalemia.
. 19.
1992
Correspondence
. 19:391.
1992
Cytokine-Induced Immunoglobulin Production in Primary IgA Nephropathy
. 20:611-617.
1992
Familial IgA Nephropathy Associated With Bilateral Sensorineural Deafness
. 19:592-596.
1992
Musculoskeletal Complications After Renal Transplantation: Pathogenesis and Treatment
. 19:99-120.
1992
Reply
. 20:531.
1992
US Minority Groups and End-Stage Renal Disease: A Disproportionate Share
. 19:411-413.
1992
Changing Patterns of End-Stage Renal Disease Due to Hypertension
. 18:336-343.
1991
Epstein-Barr virus Transformation of B Lymphocytes From IgA Nephropathy Patients and First-Degree Relatives Results in Increased Immunoglobulin Synthesis not Restricted to IgA
. 17:55-61.
1991
Long-Term Follow-Up of a Human Subject With a Remnant Kidney
. 18:509-513.
1991
Macroscopic Hematuria and Proteinuria Preceding Renal IgA Deposition in Patients With IgA Nephropathy
. 17:472-479.
1991
Selective Elevation of Monomeric IgA1 in IgA Nephropathy Patients With Normal Renal Function
. 18:313-319.
1991
C4B Deficiency in Two Siblings With IgA Nephropathy
. 15:66-71.
1990
Evaluation of Renal Transplant Dysfunction by Duplex Doppler Sonography: A Prospective Study and Review of the Literature
. 15:544-550.
1990
Tubulointerstitial Nephritis Due to Vancomycin
. 14:512-515.
1989
Immunobiology of IgA.
. 12:378-383.
1988
A Comparison of OKT3 Monoclonal Antibody and Corticosteroids in the Treatment of Acute Renal Allograft Rejection
. 11:86-89.
1988
Activation of Complement in IgA Nephropathy
. 12:437-442.
1988
Cell Surface Receptors for Kidney Basement Membranes
. 12:78-83.
1988
Familial Clustering and Immunogenetic Aspects of IgA Nephropathy
. 12:366-370.
1988
Hyperphosphatemia, Hypocalcemia, and Renal Failure in a Patient With Acute Leukemia
. 11:442-445.
1988
Immunobiology of IgA
. 12:378-383.
1988
Results of Coronary Artery Bypass Grafting in End-Stage Renal Disease
. 12:266-270.
1988
Cat-Bite Peritonitis: Pasteurella Multocida Peritonitis Following Feline Contamination of Peritoneal Dialysis Tubing
. 10:318-319.
1987
Oxalosis in Bone Causing a Radiographical Mimicry of Renal Osteodystrophy
. 9:436-440.
1987
Renal Disease and Syphilis: A Report of Nephrotic Syndrome With Minimal Change Disease
. 9:176-179.
1987
Striking Elevation of Serum IgA, IgA-Containing Immune Complexes, and IgA Rheumatoid Factor in Clinically Silent Dermatitis Herpetiformis
. 10:378-384.
1987
Treatment of Uremic Pericarditis and Pericardial Effusion
. 10:2-8.
1987
Focal Sclerosis of Hypertrophied Glomeruli in Solitary Functioning Kidneys of Humans
. 5:226-232.
1985
Hemodialysis Without Anticoagulation
. 5:32-35.
1985
Staphylococcus Aureus Bacteremia in Patients on Chronic Hemodialysis
. 6:412-419.
1985
IgA Nephropathy: Presentation, Clinical Course, and Prognosis in Children and Adults
. 4:192-200.
1984
Identity
International Standard Serial Number (issn)
0272-6386
Electronic International Standard Serial Number (eissn)
1523-6838